Almirall Reports Strong Q1 Earnings and Growth Projections

Almirall, S.A. sees a significant uptick in profits and sales for Q1. The firm forecasts 10-13% sales growth for fiscal 2025, indicating robust performance in the pharmaceutical sector.

Date: 12-05-2025

AI Rating: 8

Quarterly Performance Review
Almirall, S.A. has reported a remarkable first-quarter performance with net income surging by 192% to 21.6 million euros, compared to 7.4 million euros in the previous year. This spike indicates substantial growth in profitability and could attract investor interest, especially in the pharmaceutical sector.

Normalized net income also reflects a favorable trend, rising to 22.1 million euros from 7.5 million euros a year ago. This reinforces the company's capacity for generating profit, a crucial factor for investors assessing potential returns.

**Revenue and Growth Outlook**
Total revenue for the first quarter increased by 15% to 286.1 million euros from 248.8 million euros the year before. Additionally, net sales followed a similar growth pattern, climbing 15% to 284.6 million euros from 247.4 million euros. Such consistent revenue growth is an encouraging sign for investors, indicating that the company is effectively increasing its market share, particularly in the dermatology sector in Europe.

Projecting forward, Almirall expects double-digit net sales growth of 10-13% for fiscal 2025, alongside total EBITDA projected between 220 million euros and 240 million euros. These forecasts are likely to enhance investor confidence as they suggest a strong growth trajectory aligns with corporate strategy and market conditions.

**Profit Margins and EBITDA Growth**
EBITDA also saw a significant increase, growing 35% year-over-year to reach 70.9 million euros. This growth in EBITDA is an essential indicator of operating profitability and efficiency – critical metrics that investors monitor closely.

Overall, Almirall’s performance shows promising signs for potential investors, backed by substantial earnings growth and a positive outlook for upcoming periods.

Stocks: LBTSF.PK